LGG
AMGN icon

Luts & Greenleigh Group’s Amgen AMGN Stock Holding History

Luts & Greenleigh Group’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-671
Closed -$216K – 79
2024
Q3 		$216K Buy
671
+10
+2% +$3.27K 0.21% 78
2024
Q2 		$207K Buy
+661
New +$194K 0.21% 76

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.6B AUM 20.7% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Luts & Greenleigh Group's AMGN Position: Q4 2024 in Review

Luts & Greenleigh Group sold out of Amgen (AMGN) in Q4 2024, closing a stake of 671 shares — an estimated $216K sold.

Luts & Greenleigh Group first reported a position in AMGN in Q2 2024 and held it in 2 quarters. The position peaked at $216K in Q3 2024. 2,855 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.

  • Luts & Greenleigh Group reported no remaining Amgen position as of Q4 2024 after selling out during the quarter.
  • Luts & Greenleigh Group sold 671 Amgen shares in Q4 2024, an estimated $216K.
  • Luts & Greenleigh Group first reported a position in Amgen in Q2 2024 and held it in 2 quarters.
  • Luts & Greenleigh Group's Amgen position peaked at $216K in Q3 2024.
  • 2,855 funds tracked by Wall St. Rank held Amgen as of Q4 2024.

Based on Luts & Greenleigh Group's 13F filing for Q4 2024, filed 17 Jan 2025.